EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells

Allaura A Cox, Alice Liu, Christopher J Ng iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0298133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Allaura A Cox und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado-Anschutz Medical Campus, Aurora, CO, United States of America. Hauptthemen laut MEDLINE: Clusterin, von Willebrand Factor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Maternal and Child Health Bureau, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alterations in von Willebrand factor (VWF) have an important role in human health and disease. Deficiency of VWF is associated with symptoms of bleeding and excesses of VWF are associated with thrombotic outcomes. Understanding the mechanisms that drive VWF regulation can lead to a better understanding of modulation of VWF levels in humans. We identified clusterin ( CLU ) as a potential candidate regulator of VWF based on a single cell RNA sequencing (scRNA-seq) analysis in control endothelial cells (ECs) and von Willebrand disease (VWD) endothelial colony-forming-cells (ECFCs). We found that patients with deficiencies of VWF (von Willebrand disease, VWD) had decreased CLU expression and ECs with low VWF expression also had low CLU expression. Based on these findings, we sought to evaluate the role of CLU in the regulation of VWF, specifically as it relates to VWD. As CLU is primarily thought to be a golgi protein involved in protein chaperoning, we hypothesized that knockdown of CLU would lead to decreases in VWF and alterations in Weibel-Palade bodies (WPBs). We used both siRNA- and CRISPR-Cas9-based approaches to modulate CLU in human umbilical vein endothelial cells (HUVECs) and evaluated VWF protein levels, VWF mRNA copy number, and WPB quantity and size. We demonstrated that siRNA-based knockdown of CLU resulted in decreases in VWF content in cellular lysates and supernatants, but no significant change in WPB quantity or size. A CRISPR-Cas9-based knockdown of CLU demonstrated similar findings of decreases in intracellular VWF content but no significant change in WPB quantity or size. Our data suggests that CLU knockdown is associated with decreases in cellular VWF content but does not affect VWF mRNA levels or WPB quantity or size.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clusterinvon Willebrand FactorHumansCells, CulturedHuman Umbilical Vein Endothelial CellsRNA, MessengerRNA, Small Interferingvon Willebrand DiseasesWeibel-Palade Bodies

Substanzen

ClusterinRNA, MessengerRNA, Small Interferingvon Willebrand Factor

Autor:innen und Institutionen

  • Department of Pediatrics, University of Colorado-Anschutz Medical Campus, Aurora, CO, United States of America.
  • Department of Bioengineering, Washington University, St. Louis, MO, United States of America.

ORCID-Profile: Christopher J Ng

Förderung

  • NHLBI NIH HHS
  • Maternal and Child Health Bureau
  • National Heart, Lung, and Blood Institute
  • National Hemophilia Foundation
  • Children's Hospital Colorado Foundation

Zitieren

APA

Cox, A. A., Liu, A., & Ng, C. J. (2024). Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0298133

Vancouver

Cox AA, Liu A, Ng CJ. Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells. PLOS ONE. 2024. doi:10.1371/journal.pone.0298133

BibTeX
@article{Cox2024,
  author = {Cox, Allaura A and Liu, Alice and Ng, Christopher J},
  title = {Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0298133}
}
Kostenlos starten →